MCL1 and plasma cell myeloma: Emodin embarrasses the adhesion of human hepatocarcinoma (HepG2), human cervix epithelioid carcinoma (HeLa), and human breast cancer (MDA-MB-231) tumor cells by preventing lipid raft coalescence and impeding integrin gathering and focal adhesion complex (FAC) creation [21] and selectively prohibits the IL6-stimulated JAK2/STAT3 pathway, stimulates apoptosis in myeloma cells by the downregulation of myeloid cell leukemia 1 (Mcl-1) cells [20].